RecruitingNCT06536946
B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Expression of B-catenin in Cutaneous Squamous Cell Carcinoma and Its Mimickers
Sponsor
Sohag University
Enrollment
50 participants
Start Date
Jun 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Examine the role of B-catenin in differentiation of cutaneous squamous cell carcinoma from other lesions that may be similar to it
Eligibility
Inclusion Criteria1
- tissue blocks with sufficient materials Cases with sufficient data
Exclusion Criteria1
- tissue blocks with insufficient and necrotic materials. Casas with insufficient data
Interventions
BIOLOGICALImmunohistochemical staining
Staining of cutanous squamous cell carcinoma and its mimickers by monoclonal antibodies against human B-catenin by immunohistochemical procedures
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06536946
Related Trials
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
NCT061717505 locations
TIL Therapy in cSCC and MCC
NCT072880731 location
Ex Vivo Cutaneous SCC
NCT074026161 location
Phase 2 Study of Ivonescimab in Patients With Cutaneous Squamous Cell Carcinoma
NCT065673141 location
Thermotherapy in Addition to SOC Palliative Radiotherapy
NCT066591462 locations